R. Basser

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors

Scott N. Holden, Sabine Eckhardt, R. Basser et al. · Annals of Oncology · 2005 · 306 citations · Full text

Medicine, Oncology, Pharmacology +15

Broad inter‐individual variations in circulating progenitor cell numbers induced by granulocyte colony‐stimulating factor therapy

Andrew W. Roberts, E DeLuca, D Metcalf et al. · Stem Cells · 1995 · 71 citations

Medicine, Hematology, Oncology +11

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

M. D. Green, Prudence A. Francis, Val Gebski et al. · Annals of Oncology · 2009 · 63 citations · Full text

Medicine, Oncology, Pharmacology +12

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia

Mark Rosenthal, Danny Rischin, Grant A. McArthur et al. · Annals of Oncology · 2002 · 63 citations · Full text

Medicine, Hematology, Pharmacology +8

Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans

C. Glenn Begley, R. Basser, Rachel Mansfield et al. · Blood · 1997 · 59 citations · Full text

Life Sciences, Cell Biology, Hematology +14